These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Modulation of the immune response with T-cell epitopes: the ultimate goal for specific immunotherapy of autoimmune disease. Fairchild PJ; Thorpe CJ; Travers PJ; Wraith DC Immunology; 1994 Apr; 81(4):487-96. PubMed ID: 7518791 [No Abstract] [Full Text] [Related]
3. On the mark: genetically engineered immunotherapies for autoimmunity. Ellebrecht CT; Lundgren DK; Payne AS Curr Opin Immunol; 2019 Dec; 61():69-73. PubMed ID: 31563849 [TBL] [Abstract][Full Text] [Related]
4. Antigen-specific immunotherapy: is it a real possibility to combat T-cell-mediated autoimmunity? Tisch R; McDevitt HO Proc Natl Acad Sci U S A; 1994 Jan; 91(2):437-8. PubMed ID: 8290544 [No Abstract] [Full Text] [Related]
5. Therapeutic intervention in autoimmunity. Tisch R; Yang XD; McDevitt HO Behring Inst Mitt; 1994 Jul; (94):171-8. PubMed ID: 7998910 [No Abstract] [Full Text] [Related]
6. Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens. Durinovic-Belló I Autoimmunity; 1998; 27(3):159-77. PubMed ID: 9609134 [TBL] [Abstract][Full Text] [Related]
11. Possible role of histamine in pathogenesis of autoimmune diseases: implications for immunotherapy with histamine-2 receptor antagonists. Nielsen HJ; Hammer JH Med Hypotheses; 1992 Dec; 39(4):349-55. PubMed ID: 1362972 [TBL] [Abstract][Full Text] [Related]
12. The role of autoantigens in the driving of autoimmune diseases. Roitt IM Immunol Ser; 1993; 59():119-29. PubMed ID: 7681695 [No Abstract] [Full Text] [Related]
13. [Autoimmunity]. Müller C Schweiz Med Wochenschr; 1997 Mar; 127(9):333-40. PubMed ID: 9132931 [TBL] [Abstract][Full Text] [Related]
14. Autoimmunity: present-day concepts and future prospects. Hong R Curr Probl Pediatr; 1991 Jul; 21(6):253-8. PubMed ID: 1914513 [No Abstract] [Full Text] [Related]
15. The role of autoantigens in autoimmune disease. Mocci S; Lafferty K; Howard M Curr Opin Immunol; 2000 Dec; 12(6):725-30. PubMed ID: 11102779 [TBL] [Abstract][Full Text] [Related]
16. Speculations on mechanisms of HLA associations with autoimmune diseases and the specificity of "autoreactive" T lymphocytes. Möller E; Böhme J; Valugerdi MA; Ridderstad A; Olerup O Immunol Rev; 1990 Dec; 118():5-19. PubMed ID: 1706682 [No Abstract] [Full Text] [Related]
17. Immunospecific drug design--prospects for treatment of autoimmune diseases. Arnon R; Teitelbaum D Ther Immunol; 1994 Jan; 1(1):65-70. PubMed ID: 7584481 [TBL] [Abstract][Full Text] [Related]
18. Immunotherapy in autoimmune diseases. Miller A; Hafler DA; Weiner HL Curr Opin Immunol; 1991 Dec; 3(6):936-40. PubMed ID: 1793539 [TBL] [Abstract][Full Text] [Related]
19. Most nuclear systemic autoantigens are extremely disordered proteins: implications for the etiology of systemic autoimmunity. Carl PL; Temple BR; Cohen PL Arthritis Res Ther; 2005; 7(6):R1360-74. PubMed ID: 16277689 [TBL] [Abstract][Full Text] [Related]
20. Limited heterogeneity of autoantigens and T cells in autoimmune diseases? Acha-Orbea H Res Immunol; 1991; 142(5-6):487-90. PubMed ID: 1754724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]